Hospital Italiano de Buenos Aires
Buenos Aires, Argentina
NCT Number: NCT04793165
This is a pilot, interventional clinical trial to assess the effectiveness and safety of artificial pancreas (AP) using the ARG algorithm closed-loop system in a monitored 3-day period outpatient study. Once the safety of the device has been validated in the open-loop first 3-day period (continuous subcutaneous insulin infusion (CSII) plus continuous glucose monitoring (CGM)) the investigators will move the study to the second 3-day closed-loop period, without carbohydrate (CHO) counting.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Buenos Aires, Argentina
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
To assess efficacy and safety of non-Hybrid Closed-loop System, without CHO counting
Time frame: 3 days
Percent of time in each range according to sensor glucose readings
Time frame: 3 days
Percent of time in the target range of 70-180 mg/dl according to sensor glucose readings
Time frame: 3 days
Percent of time in range of less than 70 mg/dl according to sensor glucose readings
Hospital Italiano de Buenos Aires
Other
Is the Artificial Pancreas, Without Carbohydrate Counting, Efficient and Safe for Ambulatory Patients With Type 1 Diabetes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05168657
Autoimmune Diabetes, Autoimmune Diseases
Aurora, Colorado, United States
View Trial DetailsNCT04074668
Autoimmune Diabetes, Autoimmune Diseases
Aurora, Colorado, United States
View Trial DetailsNCT05866536
Autoimmune Diabetes, Autoimmune Diseases
Charlestown, Massachusetts, United States
View Trial DetailsNCT05319990
Autoimmune Diabetes, Autoimmune Diseases
Aurora, Colorado, United States
View Trial Details